EUVIMEDEUVIMED entdecken
Crossref

Targeting MYH9 by Usenamine A suppresses lung cancer via activation of the endoplasmic reticulum stress-autophagy axis

Dongxiao Liu, Xuejiao Wei, Huiming Huang, Yingying Tian, Fei Wang, Zhuguo Wang, Xinyu Qiu, Ruoxin Zhang, Yufeng Gao, Wanying Xie, Xiaoxue Wang, Pengfei Tu und 2 weitere

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.118342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Dongxiao Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China; Modern Research Center for Traditional Chinese Medic…. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, Lung Neoplasms, Autophagy, Myosin Heavy Chains. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Beijing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is one of the most common malignant tumors worldwide, posing a major risk to human health and survival. The identification of antitumor active compounds from natural products is a critical avenue for the development of anticancer drugs. Usenamine A (UA), a natural dibenzofuran compound extracted from Usnea longissima Ach. in our lab, has shown significant antitumor efficacy. However, the effect of UA against lung cancer and its specific mechanisms remain unclear. This study demonstrated that UA significantly inhibited lung cancer cell proliferation and induced apoptosis. Furthermore, UA induced endoplasmic reticulum (ER) expansion, markedly increased the levels of Ca2+, and significantly upregulated the expression of ER stress-related proteins, including HSPA5, p-PERK, p-eIF2α, ATF4, and CHOP, in these cells. Therefore, UA induced ER stress in lung cancer cells. Furthermore, UA-induced ER stress contributed to its lung cancer-suppressive activity. Additionally, UA-induced autophagy activation was implicated in its lung cancer-suppressive activity. The induction of ER stress activated autophagy in lung cancer cells. Moreover, the inhibition of ER stress considerably impaired the activation of autophagy induced by UA in lung cancer cells. Consequently, UA activated the ER stress-autophagy axis in lung cancer cells. In addition, myosin heavy chain 9 (MYH9) was identified as a target of UA in lung cancer cells, and MYH9 knockdown compromised UA-induced ER stress in these cells. In vivo, UA significantly inhibited tumor growth in a subcutaneous syngeneic Lewis lung carcinoma (LLC) model in C57BL/6J mice, achieving a tumor inhibition rate of 57.20%. Furthermore, UA induced ER stress and altered autophagy-related markers in LLC tumor tissues. In summary, UA exerted its lung cancer-suppressive activity by activating the PERK/eIF2α/ATF4/CHOP signaling cascade to drive the ER stress-autophagy axis and ultimately inducing apoptosis, with MYH9 acting as a crucial target of UA-induced ER stress in lung cancer cells. UA may serve as a promising lead compound for further development against lung cancer, while MYH9 emerged as a promising therapeutic target for lung cancer. This study offered a novel strategy for lung cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoplasmic Reticulum StressLung NeoplasmsAutophagyMyosin Heavy ChainsHumansAnimalsMiceEndoplasmic Reticulum Chaperone BiPAntineoplastic AgentsCell Line, TumorCell ProliferationApoptosisMaleA549 Cells

Stichwörter der Autor:innen

ApoptosisAutophagyEndoplasmic reticulum stressLung cancerMYH9Usenamine A

Substanzen

Myosin Heavy ChainsHSPA5 protein, humanMYH9 protein, humanEndoplasmic Reticulum Chaperone BiPHspa5 protein, mouseAntineoplastic Agents

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China; Modern Research Center for Traditional Chinese Medicine, Beijing Research Institute of Chinese Medicine, Beijing Universit…
  • School of Traditional Chinese Medicine, Binzhou Medical University, Yantai 264003, China.
  • Modern Research Center for Traditional Chinese Medicine, Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: quchanghai@bucm.edu.cn.
  • Modern Research Center for Traditional Chinese Medicine, Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: zdhu@bucm.edu.cn.

Förderung

  • Fundamental Research Funds for the Central Universities
  • Beijing University of Chinese Medicine

Zitieren

APA

Liu, D., Wei, X., Huang, H., Tian, Y., Wang, F., Wang, Z., Qiu, X., Zhang, R., Gao, Y., Xie, W., Wang, X., Tu, P., Qu, C., & Hu, Z. (2026). Targeting MYH9 by Usenamine A suppresses lung cancer via activation of the endoplasmic reticulum stress-autophagy axis. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118342

Vancouver

Liu D, Wei X, Huang H, Tian Y, Wang F, Wang Z, et al. Targeting MYH9 by Usenamine A suppresses lung cancer via activation of the endoplasmic reticulum stress-autophagy axis. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118342

BibTeX
@article{Liu2026,
  author = {Liu, Dongxiao and Wei, Xuejiao and Huang, Huiming and Tian, Yingying and Wang, Fei and Wang, Zhuguo and Qiu, Xinyu and Zhang, Ruoxin and Gao, Yufeng and Xie, Wanying and Wang, Xiaoxue and Tu, Pengfei and Qu, Changhai and Hu, Zhongdong},
  title = {Targeting MYH9 by Usenamine A suppresses lung cancer via activation of the endoplasmic reticulum stress-autophagy axis},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.118342}
}
Kostenlos starten →